Denton and Reddish MP Andrew Gwynne has backed a campaign by Muscular Dystrophy UK to give people with devastating muscle-wasting conditions faster access to life-saving treatments.
The charity recently held its first ever Fast Track event in Parliament, bringing together people with muscular dystrophy, their MPs, representatives from the pharmaceutical industry and the National Institute for Health and Care Excellence (NICE).
Andrew Gwynne heard how lengthy and unnecessary delays to the UK’s drug approval process is putting lives at risk. As many muscle-wasting conditions progress rapidly, fast access to treatments is crucial.
He is backing the charity’s call for:
- The NHS to be given more powers to negotiate good deals with pharmaceutical companies, to help streamline access to treatments
- A more appropriate NICE assessment model for rare disease drugs like Spinraza
- Early access schemes, which bring treatments to patients faster, to be implemented as soon as possible.
Andrew Gwynne said:
“As muscle-wasting conditions progress rapidly, people with muscular dystrophy must get rapid access to the new, breakthrough drugs that are emerging.
“Meeting those affected by this cruel condition really hit home just how much of a lifeline these treatments are. That’s why I’m supporting the Fast Track campaign.”